Cargando…

Thalassemia Intermedia and Acute Lymphoblastic Leukemia: Is it a Coincidental Double Diagnosis?

Detalles Bibliográficos
Autores principales:	Tuğcu, Deniz, Karakaş, Zeynep, Gökçe, Müge, Ağaoğlu, Leyla, Ünüvar, Ayşegül, Sarıbeyoğlu, Ebru, Akçay, Arzu, Devecioğlu, Ömer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2014
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287036/ https://www.ncbi.nlm.nih.gov/pubmed/25330528 http://dx.doi.org/10.4274/tjh.2014.0068

Ejemplares similares

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012)

Clofarabine Experience in Children with Multi-Relapsed Acute Leukemia
por: Karakaş, Zeynep, et al.
Publicado: (2014)

A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia
por: Hatırnaz Ng, Özden, et al.
Publicado: (2015)

PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia
por: Küçükcankurt, Fulya, et al.
Publicado: (2020)

Bone Marrow Involvement of Rhabdomyosarcoma from Unknown Origin
por: Koç, Begüm Şirin, et al.
Publicado: (2014)

Hepatitis B Vaccination in Children With Ongoing Cancer Treatment: A Safety and Efficacy Study of Super-Accelerated Vaccination Scheme
por: Ocak, Suheyla, et al.
Publicado: (2021)

Acute lymphoblastic leukemia in a β-thalassemia intermedia child: A case report
por: Sherief, Laila M, et al.
Publicado: (2020)

Analysis of Chromosomal Aberrations and FLT3 gene Mutations in Childhood Acute Myelogenous Leukemia Patients
por: Coşkunpınar, Ender, et al.
Publicado: (2012)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
por: Şahin, Şifa, et al.
Publicado: (2022)

Endocrine Function in Thalassemia Intermedia
por: Karamifar, H., et al.
Publicado: (2006)

Guillain–Barre syndrome in acute lymphoblastic leukemia: Causal or coincidental
por: Bhushan, Bharat, et al.
Publicado: (2015)

Prognostic Significance of NOTCH1 and FBXW7 Mutations in Pediatric T-ALL
por: Erbilgin, Yucel, et al.
Publicado: (2010)

Evaluation of Alpha-Thalassemia Mutations in Cases with Hypochromic Microcytic Anemia: The İstanbul Perspective
por: Karakaş, Zeynep, et al.
Publicado: (2015)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Did the Proband Have Thalassemia Intermedia or Severe Thalassemia Trait?
por: Özsoylu, Şinasi
Publicado: (2012)

Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia
por: Yasa, Beril, et al.
Publicado: (2011)

Evaluation of Cardiac Function in Patients with Thalassemia Intermedia
por: Nouri, NM, et al.
Publicado: (2013)

Secondary Haemochromatosis in a Patient with Thalassemia Intermedia
por: ROTARU, IONELA, et al.
Publicado: (2014)

Protein C and S levels in patients with Thalassemia intermedia
por: Mohammed, Nawsherwan Sadiq
Publicado: (2022)

β-Thalassemia Intermedia in Northern Iraq: A Single Center Experience
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2014)

Congenital Factor Deficiencies in Children: A Report of a Single-Center Experience
por: Şalcıoğlu, Zafer, et al.
Publicado: (2017)

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
por: Zekavat, Omid Reza, et al.
Publicado: (2014)

β-Thalassemia Intermedia: A Bird’s-Eye View
por: Haddad, Anthony, et al.
Publicado: (2014)

Echocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq
por: Mohammad, Ameen Mosa
Publicado: (2014)

Tophaceous gout in thalassemia intermedia: a rare association
por: Mishra, Vikas, et al.
Publicado: (2016)

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?
por: Komninaka, Veroniki, et al.
Publicado: (2023)

Pediatric Case of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity
por: Gündüz, Mehmet, et al.
Publicado: (2022)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq
por: Amin, Shaema Salih, et al.
Publicado: (2020)

Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea
por: Khavari, Maryam, et al.
Publicado: (2014)

Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
por: Alfaqih, Mahmoud A., et al.
Publicado: (2018)

Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine
por: Faraon, Rashail, et al.
Publicado: (2019)

Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia
por: Isa Tafreshi, Roya, et al.
Publicado: (2022)

P1456: MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA
por: Meloni, Antonella, et al.
Publicado: (2023)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Double heterozygocity for hemoglobin C and beta thalassemia dominant: A rare case of thalassemia intermedia
por: Agapidou, Alexandra, et al.
Publicado: (2018)

Corrigendum to “Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq”
por: Amin, Shaema Salih, et al.
Publicado: (2020)

β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain
por: Ropero, Paloma, et al.
Publicado: (2022)

Cyclic headaches in β-thalassemia intermedia case presenting as moyamoya syndrome
por: Akpınar, Süha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gd287ou2g4dbb32bati4ca3btv